Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Soci

Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Soci#Applied #Therapeutics #Presents #Full #12Month #Clinical #Results #Topline #Data #INSPIRE #Phase #Trial #Govorestat #CMTSORD #LateBreaking #Oral #Presentation #Peripheral #Nerve #Soci